Results for paresis translation from English to Maltese

paresis
paresi

one case of sensory-motor paresis was reported.
kien irrappurtat każ wieħed ta ’ paresi tal- mutur sensorju.

headache encephalopathy convulsion cerebral haemorrhage memory impairment paresis
uġigħ ta’ ras enċefalopatija konvulżjoni emorraġija ċerebrali nuqqas ta’ memorja paresi

central nervous symptoms such as vertigo, walking instability and hemi-paresis have been observed with accidental exalief overdose.
sintomi tas-sistema nervuża ċentrali bħal ma huma mejt, instabbilità fil-mixi u hemiparesis ġew osservati b’teħid eċċessiv aċċidentali ta’ exalief.

central nervous symptoms such as vertigo, walking instability and hemi-paresis have been observed with accidental eslicarbazepine acetate overdose.
sintomi tas-sistema nervuża ċentrali bħal ma huma mejt, instabbilità fil-mixi u hemiparesis ġew osservati b’teħid eċċessiv aċċidentali ta’ eslicarbazepine acetate.

cranial nerve palsies, vocal cord paresis, and rare reports of severe hypersensitivity reactions have been reported during post-marketing surveillance of abraxane.
palsi tan-nervituri tal-kranju, paresi tal-kordi vokali, u rapporti rari ta’ reazzjonijiet severi ta’ sensittività eċċessiva waqt is-sorveljanza ta’ wara t-tqegħid fis-suq ta’ abraxane.

guillain-barré syndrome, demyelination, myasthenic syndrome, autoimmune neuropathy (including facial and abducens nerve paresis)
is-sindrome ta’ guillain-barré, demajelinazzjoni, sindrome majesteniku, newropatija awtoimmuni (inkluż pareżi tal-wiċċ u tan-nevituri abduċeni)

peak plasma concentrations are reached at 6 hours following administration in a postoperative period due to contributing factors such as anaesthesia, gastrointestinal paresis, and surgical effects independent of the oral medicinal product formulation.
il-konċentrazzjonijiet massimi fil-plażma jintlaħqu 6 sigħat wara l-għoti fil-perjodu ta’ wara l- operazzjoni minħabba fatturi li jikkontribwixxu, bħal loppju, paresi gastrointestinali, u l-effetti kirurġiċi indipendentement mill-formulazzjoni orali tal-prodott mediċinali.

encephalo- pathy, central nervous system haemorrhages and cerebrovascul ar accidents, coma, speech and language ab- normalities, paralysis and paresis, amnesia
emorraġiji fis- sistema nervuża ċentrali u inċidenti ċerebrovaskula ri, koma, anormalitajiet fid-diskors u fil-lingwa, paraliżi u paresi, amnesija

among rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and plaque psoriasis patients in placebo-controlled, active-controlled, and open-label trials of enbrel, serious adverse events reported included malignancies (see below), asthma, infections (see below), heart failure, myocardial infarction, myocardial ischaemia, chest pain, syncope, cerebral ischaemia, hypertension, hypotension, cholecystitis, pancreatitis, gastrointestinal haemorrhage, bursitis, confusion, depression, dyspnoea, abnormal healing, renal insufficiency, kidney calculus, deep vein thrombosis, pulmonary embolism, membranous glomerulonephropathy, polymyositis, thrombophlebitis, liver damage, leucopenia, paresis, paresthesia, vertigo, allergic alveolitis, angioedema, scleritis, bone fracture, lymphadenopathy, ulcerative colitis, intestinal obstruction, eosinophilia, haematuria, and sarcoidosis.
fost il- pazjenti bl- artrite rewmatojde, bl- artrite psorjatika, u bl- immobilità tal- vertebra kawża ta ’ infjammazzjoni u psorjasi tal- plakka fi studji kkontrollati bi plaċebo, ikkontrollati attivament u open - 10 label b’ enbrel, ġew rrappurtati reazzjonijiet avversi serji inklużi tumuri malinni (ara taħt), ażma, infezzjonijiet, (ara taħt) insuffiċjenza tal- qalb, infart mijokardijaku, iskemja mijokardijaka, uġigħ fis - sider, sinkope, iskemja ċerebrali, pressjoni għolja, pressjoni baxxa, koleċistite, pankreatite, ħemoraġija gastrointestinali, burżite, konfużjoni, dipressjoni, dispneja, fejqan annormali, insuffiċjenza renali, ġebla fil- kliewi, trombożi fil- vini fondi, emboliżmu pulmonari, nefropatija glomerulari fir- riti, polimijosite, tromboflebite, ħsara fil- fwied, lewkopenja, pareżi, paresteżja, sturdament, alveolite allerġika, anġjoedema, sklerite, ksur fl- għadam, limfadenopatija, kolite ulċerativa u ostruzzjoni fl - imsaren, eosinofilja, ematurja, u sarkojdożi.